medigraphic.com
ISSN 2007-3178 (Print)
Asociación Mexicana de Cirugía Bucal y Maxilofacial, Colegio Mexicano de Cirugía Bucal y Maxilofacial, A.C.

2013, Number 3

<< Back Next >>

Rev Mex Cir Bucal Maxilofac 2013; 9 (3)

Mandibular mucormycosis: A rare site of occurrence. Clinical case report

Romero J, Chávez MA, Arreola R

Language: Spanish
References: 13
Page: 84-88
PDF size: 302.78 Kb.


ABSTRACT

Case report of an unusual presentation of mucormycosis in the mandible and chronic renal failure in a 53 years old man, with poor prognosis, fatal outcome, and the diagnosis was established histological by incisional biopsy; the treatment was radical, handle by medication and surgery.


REFERENCES

  1. Gregory JE, Golden A, Haymaker W. Mucormycosis of the central nervous system. A report of three cases. Bull Johns Hopkins Hosp. 1943; 73: 405-415.

  2. Parfrey NA. Improved diagnosis and prognosis of mucormycosis: A clinicopathological study of 33 cases. Medicine. 1986; 65: 113-123.

  3. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Int Med. 1972; 77: 871-879.

  4. Benbow EW, Stoddart RW. Systemic zygomycosis. Postgrad Med J. 1986; 62: 985-996.

  5. Record, NS Jr, Ginder DR. Pulmonary phycomycosis without obvious predisposing factors. JAMA. 1976; 235: 1256-1257.

  6. O’Neill BM, Alessi AS, George, EB Piro J. Disseminated rhinocerebral mucormycosis: a case report and review of the literature. Journal of Oral and Maxillofacial Surgery. 2006; 64 (2): 326-333.

  7. Brown OE, Finn R. Mucormycosis of the mandible. Journal of Oral and Maxillofacial Surgery. 1986; 44 (2): 132-136.

  8. Ananthnarayan R, Paniker CKJ., Medical mycology. In: Ananthnarayan R, Paniker CKJ. Textbook of Microbiology. 6th edition. Chennai, India: Orient Longman; 2000. pp. 564-567.

  9. Marx RE, Stern D. Inflammatory, reactive and infectious diseases. In: Marx RE, Stern D. Oral & Maxillofacial Pathology. Carol Stream, Ill., USA: Quintessence Publishing; 2003. pp. 104-106.

  10. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982; 31 (12): 1109-1114.

  11. Ibrahim A, Edwards JE Jr, Filler SG. Zygomycosis. Philadelphia, Pa., USA: Harcourt Brace; 2004.

  12. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. The Lancet Infectious Diseases. 2005; 5 (12): 775-785.

  13. Davis JC. Hyperbaric oxygen therapy. Journal of Intensive Care Medicine. 1989; 4 (2): 55-57.




2020     |     www.medigraphic.com